All Updates

All Updates

icon
Filter
Partnerships
Walgreens partners with BARDA to enhance decentralized clinical trials for public health emergencies
Clinical Trial Technology
Aug 19, 2024
This week:
Partnerships
Microsoft and BlackRock partner to launch USD 30 billion AI data center investment fund
Machine Learning Infrastructure
Today
Funding
Limitless Labs raises USD 3 million in pre-seed funding to develop prediction market
Web3 Ecosystem
Today
Product updates
Google Cloud launches Blockchain RPC service for Web3 developers
Web3 Ecosystem
Today
Product updates
Kore.ai launches GALE platform for enterprise GenAI adoption
Machine Learning Infrastructure
Today
Product updates
Kore.ai launches GALE platform for enterprise GenAI adoption
Generative AI Infrastructure
Today
Product updates
ProAmpac launches enhanced online pouch configurator MAKR by DASL for custom flexible packaging prototypes
Smart Packaging Tech
Yesterday
Funding
M&A
Majority stake in Bollegraaf Group acquired by Summa Equity for EUR 800 million
Waste Recovery & Management Tech
Yesterday
Partnerships
NASA awards Intuitive Machines contract for near-space network services
Space Travel and Exploration Tech
Yesterday
Partnerships
FinFit partners with Sunny Day Fund to offer emergency savings accounts
Financial Wellness Tools
Yesterday
Partnerships
KSP partners with Peak Technologies and Locus Robotics for warehouse automation
Logistics Tech
Yesterday
Clinical Trial Technology

Clinical Trial Technology

Aug 19, 2024

Walgreens partners with BARDA to enhance decentralized clinical trials for public health emergencies

Partnerships

  • Walgreens, a retail pharmacy chain, has partnered with the Biomedical Advanced Research and Development Authority (BARDA), part of the US Department of Health and Human Services, to strengthen decentralized clinical trials through the Decentralized Clinical Operations for Healthcare and Research (D-COHRe) program.

  • The partnership, valued at up to USD 100 million, will utilize Walgreens' clinical trial ecosystem to validate, pilot, and implement new products, technologies, and approaches for remote clinical trials during public health emergencies. This collaboration aims to make clinical research more accessible and representative of the US population, addressing current challenges such as low enrollment rates and limited participant diversity.

  • Walgreens' platform has reached over five million potential trial participants since 2022, demonstrating its effectiveness in patient recruitment. The partnership also builds on a previous collaboration between Walgreens and BARDA for a Phase IV observational Covid-19 trial to enhance US public health preparedness.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.